Compile Data Set for Download or QSAR
Report error Found 165 of ic50 data for complexid = 50004686
TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251408(US9452990, 90)
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251420(US9452990, 102)
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251413(US9452990, 95)
Affinity DataIC50: 3nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251449(US9452990, 131)
Affinity DataIC50: 3nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251397(US9452990, 77)
Affinity DataIC50: 4nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251411(US9452990, 93)
Affinity DataIC50: 4nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251348(US9452990, 28)
Affinity DataIC50: 5nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251330(US9452990, 10)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251345(US9452990, 25)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251451(US9452990, 80)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251402(US9452990, 84)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251412(US9452990, 94)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251416(US9452990, 98)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251417(US9452990, 99)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251384(US9452990, 64)
Affinity DataIC50: 7nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251389(US9452990, 69)
Affinity DataIC50: 7nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251410(US9452990, 92)
Affinity DataIC50: 8nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251378(US9452990, 58)
Affinity DataIC50: 9nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251364(US9452990, 44)
Affinity DataIC50: 10nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251387(US9452990, 67)
Affinity DataIC50: 10nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251414(US9452990, 96)
Affinity DataIC50: 10nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251448(US9452990, 130)
Affinity DataIC50: 10nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251328(US9452990, 8)
Affinity DataIC50: 11nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251346(US9452990, 26)
Affinity DataIC50: 11nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251415(US9452990, 97)
Affinity DataIC50: 11nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251409(US9452990, 91)
Affinity DataIC50: 12nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251419(US9452990, 101)
Affinity DataIC50: 13nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251349(US9452990, 29)
Affinity DataIC50: 14nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251343(US9452990, 23)
Affinity DataIC50: 15nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251421(US9452990, 103)
Affinity DataIC50: 15nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251322(US9452990, 2)
Affinity DataIC50: 16nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251342(US9452990, 22)
Affinity DataIC50: 17nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251327(US9452990, 7)
Affinity DataIC50: 20nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251329(US9452990, 9)
Affinity DataIC50: 20nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251338(US9452990, 18)
Affinity DataIC50: 20nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251380(US9452990, 60)
Affinity DataIC50: 20nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251418(US9452990, 100)
Affinity DataIC50: 20nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251439(US9452990, 121)
Affinity DataIC50: 20nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251385(US9452990, 65)
Affinity DataIC50: 30nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251401(US9452990, 83)
Affinity DataIC50: 30nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251406(US9452990, 88)
Affinity DataIC50: 30nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251407(US9452990, 89)
Affinity DataIC50: 30nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251357(US9452990, 37)
Affinity DataIC50: 40nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251363(US9452990, 43)
Affinity DataIC50: 40nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251366(US9452990, 46)
Affinity DataIC50: 40nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251381(US9452990, 61)
Affinity DataIC50: 40nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251404(US9452990, 86)
Affinity DataIC50: 40nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251405(US9452990, 87)
Affinity DataIC50: 40nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251365(US9452990, 45)
Affinity DataIC50: 50nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandPNGBDBM251373(US9452990, 53)
Affinity DataIC50: 50nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

Displayed 1 to 50 (of 165 total ) | Next | Last >>
Jump to: